Table 3 Diagnostic yield of aCGH in the prenatal diagnostics of the fetuses with ultrasound anomalies and/or increased nuchal translucency. In order to present the more relevant diagnostic yield evaluation, we only included the studies, reporting on more than 100 cases
From: Clinical utility of array comparative genomic hybridisation in prenatal setting
First author | Number of samples with US anomalies or increased NT | Diagnostic yield (%) |
|---|---|---|
Schaffer et al., 2012 [5] | 2081 | 6.3% |
Srebniak et al., 2016 [6] | 957 | 6.0% |
Wapner et al., 2012 [7] | 755 | 6.0% |
OUR STUDY | 200 | 7,0% |
Lee et al., 2012 [13] | 180 | 11.1% |
Yatsenko et al., 2013 [24] | 162 | 5.0% |
Armengol et al., 2012 [10] | 159 | 5.7% |
Rooryck et al., 2013 [25] | 142 | 11.3% |
Tyreman et al., 2009 [26] | 106 | 6.7% |
Ganesamoorthy et al, 2013 [27] | 101 | 6,9% |